Cordero-Pérez Paula, Tijerina-Márquez Ramiro, Rivas-Galindo Veronica Mayela, Torres-González Liliana, Rodríguez-Rodríguez Diana Raquel, Mendoza-Hernández Oscar Humberto, Espinosa-Cantú César Bigran, Solís-Cruz Guadalupe Yazmín, Muñoz-Espinosa Linda E, Pérez-Rodríguez Edelmiro, Cura-Esquivel Idalia, Alarcón-Galván Gabriela, Moreno-Pena Diana Patricia
Liver Unit, Department of Internal Medicine, University Hospital "Dr. José E. González", Universidad Autónoma de Nuevo León, Ave Madero and Ave Gonzalitos s/n, Colonia Mitras Centro, Monterrey, Nuevo Leon, 64460, Mexico.
Analytic Chemistry Department, School of Medicine, Universidad Autónoma de Nuevo León, Ave Madero and Ave Gonzalitos s/n, Colonia Mitras Centro, Monterrey, Nuevo Leon, 64460, Mexico.
BMC Complement Med Ther. 2025 Jun 7;25(1):207. doi: 10.1186/s12906-025-04914-x.
Understanding liver diseases is important worldwide due to their prevalence. Apart from liver disease arising from hepatitis C viral infection, most chronic liver diseases currently have no cure. Several therapeutic alternatives, including some natural products, have been proposed to treat liver diseases. The natural product Jatropha dioica has been reported to possess antioxidant activity and, by extension, could have hepatoprotective activity. Accordingly, our aim was to test the hypothesis that an extract of J. dioica is protective against liver damage induced by valproic acid (VPA).
Twelve male and twelve female Wistar rats were sorted into four groups: control, non-toxicity, valproic acid control (VPA-C), and J. dioica + VPA (JdVPA). J. dioica (300 mg/kg, given orally) was used as treatment, followed by a concomitant injection of VPA (500 mg/kg, i.p.) for the first 4 days to induce liver injury. To evaluate the severity of the injury, liver function tests were performed. In addition, oxidative stress biomarkers were quantified, as well as measures of the expression of the genes Actb, Il6, and Nfkb1.
The VPA-C group showed a significant increase in alanine aminotransferase (ALT), aspartate aminotransferase (AST), and malondialdehyde (MDA), a decrease in superoxide dismutase (SOD), and a reduction in glutathione (GSH) vs the control group. The JdVPA group showed a significant decrease in ALT, AST, and MDA and an increase in GSH and SOD vs the VPA-C group. Gene expression of Il6 and Nfkb1 did not show any statistically significant differences between study groups. Histologically, VPA presented an inflammatory infiltrate, which decreased in the JdVPA group.
The extract of J. dioica at the administered dose did not display toxicity and was capable of ameliorating the liver injury generated by VPA in biochemical and oxidative stress biomarkers, which suggests its potential hepatoprotective activity.
由于肝脏疾病的普遍性,对其的了解在全球范围内都很重要。除了丙型肝炎病毒感染引起的肝脏疾病外,目前大多数慢性肝脏疾病都无法治愈。已经提出了几种治疗方法,包括一些天然产物,用于治疗肝脏疾病。据报道,天然产物二乔麻风树具有抗氧化活性,因此可能具有肝脏保护活性。因此,我们的目的是检验二乔麻风树提取物对丙戊酸(VPA)诱导的肝损伤具有保护作用这一假设。
将12只雄性和12只雌性Wistar大鼠分为四组:对照组、无毒组、丙戊酸对照组(VPA-C)和二乔麻风树+VPA组(JdVPA)。使用二乔麻风树(300mg/kg,口服)进行治疗,随后在前4天同时注射VPA(500mg/kg,腹腔注射)以诱导肝损伤。为了评估损伤的严重程度,进行了肝功能测试。此外,对氧化应激生物标志物进行了定量分析,并检测了Actb、Il6和Nfkb1基因的表达情况。
与对照组相比,VPA-C组的丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)和丙二醛(MDA)显著升高,超氧化物歧化酶(SOD)降低,谷胱甘肽(GSH)减少。与VPA-C组相比,JdVPA组的ALT、AST和MDA显著降低,GSH和SOD增加。Il6和Nfkb1的基因表达在各研究组之间未显示出任何统计学上的显著差异。组织学上,VPA呈现炎症浸润,而在JdVPA组中炎症浸润减少。
在所给剂量下,二乔麻风树提取物未显示出毒性,并且能够改善VPA在生化和氧化应激生物标志物方面产生的肝损伤,这表明其具有潜在的肝脏保护活性。